Presentation TCT 2013 Rapid-Acting Potent IV P2Y12 Inhibition: Evolution or Revolution? Presenter: Robert Harrington October 27, 2013
Presentation TCT 2013 LAA Closure is Now Established - The Added Value of New Randomized Trials Would be Minimal! Presenter: Matthew Price October 27, 2013
Presentation TCT 2013 PFO Closure Would Benefit from a CHADS-Like Score to Select the Patients Who Will Benefit Presenter: David Thaler October 27, 2013
Presentation TCT 2013 The Spectrum of Current and Future Renal Denervation Clinical Trials Presenter: Mehdi Shishehbor October 27, 2013
Presentation TCT 2013 Emerging Technologies for CLI: Advantages to Working Together Presenter: Hiroyoshi Yokoi October 27, 2013
Presentation TCT 2013 Extra-vascular Focused Ultrasonic Denervation (Kona Medical) Presenter: Todd Brinton October 27, 2013
Presentation TCT 2013 Japan-US Zilver Stent Study and Approval: Lessons Learned and Future Options Presenter: Neal Fearnot October 27, 2013
Presentation TCT 2013 Connecting the Disparate Dots: The Development of the TIPS Procedure Presenter: Barry Katzen October 27, 2013
Presentation TCT 2013 Keynote Lecture: A Clinical and Entrepreneurial Vision of Japan-US Synergies and Health Technologies Presenter: Peter Fitzgerald October 27, 2013
Presentation TCT 2013 ReZolve Sirolimus-eluting BRS Based on an Iodinated Tyrosine Derivative: Device Iteration and Extended Imaging and Clinical Results Presenter: Ricardo Costa October 27, 2013